211 related articles for article (PubMed ID: 15388112)
1. A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir.
Rivard MJ; Kirk BL; Stapleford LJ; Wazer DE
Appl Radiat Isot; 2004 Dec; 61(6):1211-6. PubMed ID: 15388112
[TBL] [Abstract][Full Text] [Related]
2. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
3. Comparison of air kerma standards of LNE-LNHB and NPL for 192Ir HDR brachytherapy sources: EUROMET project no 814.
Douysset G; Sander T; Gouriou J; Nutbrown R
Phys Med Biol; 2008 Mar; 53(6):N85-97. PubMed ID: 18367784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
[TBL] [Abstract][Full Text] [Related]
5. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
Richter J; Baier K; Flentje M
Strahlenther Onkol; 2008 Apr; 184(4):187-92. PubMed ID: 18398582
[TBL] [Abstract][Full Text] [Related]
7. On the need for massive additional shielding of a catheterization laboratory for the implementation of high dose rate 192Ir intravascular brachytherapy.
Bohan M; Yue N; Nath R
Cardiovasc Radiat Med; 2000; 2(1):39-41. PubMed ID: 11229061
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency.
Nag S; Dally M; de la Torre M; Tatsuzaki H; Kizilbash N; Kurusun S; Pinillos L; Pokrajac B; Sur R; Levin V
Radiother Oncol; 2002 Sep; 64(3):297-308. PubMed ID: 12242118
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
10. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
[TBL] [Abstract][Full Text] [Related]
11. Measured microdosimetric spectra and therapeutic potential of boron neutron capture enhancement of 252Cf brachytherapy.
Burmeister J; Kota C; Maughan RL
Radiat Res; 2005 Sep; 164(3):312-8. PubMed ID: 16137204
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of Fricke dosimetry as an absorbed dose to water standard for 192Ir HDR sources.
deAlmeida CE; Ochoa R; Lima MC; David MG; Pires EJ; Peixoto JG; Salata C; Bernal MA
PLoS One; 2014; 9(12):e115155. PubMed ID: 25521914
[TBL] [Abstract][Full Text] [Related]
13. [192Ir brachytherapy].
Inoue T; Inoue T; Yamazaki H; Tian TJ; Ohzeki S; Teshima T; Ohtani M; Nose T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2120-5. PubMed ID: 8239675
[TBL] [Abstract][Full Text] [Related]
14. Air kerma standard and measurement comparison on source strength determination for high-dose rate 192Ir brachytherapy in Taiwan.
Lee JH; Su SH; Hsieh MT; Chen IJ; Liang JA; Hsu SM
Radiat Prot Dosimetry; 2011 Jul; 146(1-3):100-2. PubMed ID: 21498859
[TBL] [Abstract][Full Text] [Related]
15. [Patterns of the formation of a dosage field in arranging 252Cf and 60Co sources in a single plane].
Ivanov VN; Vtiurin BM; Ivanova LF; Kondzhariia IuR
Med Radiol (Mosk); 1983 Mar; 28(3):38-42. PubMed ID: 6835057
[TBL] [Abstract][Full Text] [Related]
16. IRIDIUM-192 RADIOTHERAPY BENEFITS IN THE MANAGEMENT OF GYNECOLOGICAL TUMORS.
Ivankova VS; Domina EA; Khrulenko TV; Baranovska LM; Hrinchenko OO
Probl Radiac Med Radiobiol; 2020 Dec; 25():569-578. PubMed ID: 33361862
[TBL] [Abstract][Full Text] [Related]
17. Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.
Rivard MJ; Wierzbicki JG; Van den Heuvel F; Martin RC; McMahon RR
Med Phys; 1999 Jan; 26(1):87-96. PubMed ID: 9949403
[TBL] [Abstract][Full Text] [Related]
18. Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.
Rivard MJ; Zamenhof RG
Appl Radiat Isot; 2004 Nov; 61(5):753-7. PubMed ID: 15308139
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications.
Glaser FH
Sonderb Strahlenther Onkol; 1988; 82():106-13. PubMed ID: 3134704
[No Abstract] [Full Text] [Related]
20. Toward endobronchial Ir-192 high-dose-rate brachytherapy therapeutic optimization.
Gay HA; Allison RR; Downie GH; Mota HC; Austerlitz C; Jenkins T; Sibata CH
Phys Med Biol; 2007 Jun; 52(11):2987-99. PubMed ID: 17505084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
